The top 10 generic drug makers by 2021 revenue
4.6 (723) · € 20.99 · Auf Lager
After a period of stagnant sales largely because of increased competition and pricing pressures, the generic drug industry took another hit during the coronavirus pandemic. In its 10-K annual report to the Securities and Exchange Commission, generics giant Teva described how the pandemic impacted sales of its copycat drugs. The company noted that "supply discontinuities due to regulatory actions, labor disturbances and approval delays" all affected its overall performance. The drugmaker likely wasn't alone. | Many producers of generic drugs have struggled to achieve growth in recent years due to pricing pressures. But there are promising signs that the industry is ready for an uptick, and they were evident in 2021 as eight of the top 10 companies by generics sales realized growth.
Generic-drug maker Teva steals market share from Big Pharma - Aug. 5, 2009
Top 20 Generics Pharma Companies Based on 2021 Total Revenue
Generic drugs Market Size, Share & Trends 2027
Research and Development in the Pharmaceutical Industry
Top 20 Generics Pharma Companies Based On 2020 Revenue
Fastest Growing Biotech and Pharma Companies in 2023 - Xtalks
Top 20 Generics Pharma Companies Based on 2022 Revenue
50 of 2021's best-selling pharmaceuticals
50 of 2021's best-selling pharmaceuticals
